Immutep Limited (NASDAQ: IMMP) shares are trading down -26.19% at $4.2 at the time of writing after reporting that its Chinese partner, EOC Pharma will begin a new Phase II clinical trial in up to 152 metastatic breast cancer patients in China. Company’s 52-week ranged between $0.53 to $3.10. Analysts have a consensus price target of $7.75.
SELLAS Life Sciences Group Inc. (SLS) stock plunged -24.18% to $13.39 in the pre-market trading. The most recent rating by Oppenheimer, on November 01, 2018, is an Outperform.
Veru Inc. (VERU) tumbled over -11.89% at $5.26 in pre-market trading today. The firm recently declared that it has exclusively licensed phase 3 clinical stage targeted therapy for endocrine resistant metastatic breast cancer.
Before the trading started on December 11, 2020, Professional Diversity Network Inc. (IPDN) is down -25.0% to reach $1.53. It has been trading in a 52-week range of $0.76 to $3.98.
Neos Therapeutics Inc. (NEOS), a Drug Manufacturers – Specialty & Generic company, dropped about -16.36% at $0.6832 in pre-market trading Friday after announcing definitive merger agreement with Aytu BioScience, pursuant to which Neos will merge with a wholly owned subsidiary of Aytu in an all-stock transaction.
Callon Petroleum Company (CPE) is down more than -0.53% at $15.0 in pre-market hours Friday December 11, 2020. The stock had jumped over 7.71% to $15.08 in the last trading session.
C3.ai Inc. (AI) stock moved down -5.38 percent to $123.0 in the pre-market trading. The company lately declared the pricing of its initial public offering of 15,500,000 shares of its Class A common stock at a price of $42.00 per share.
Hepion Pharmaceuticals Inc. (NASDAQ: HEPA) shares are trading up 2.21% at $1.85 at the time of writing. Company’s 52-week ranged between $1.00 to $6.90. Analysts have a consensus price target of $14.
Regulus Therapeutics Inc. (RGLS) stock plunged -9.92% to $1.09 in the pre-market trading. The healthcare company revealed closing of $19.4 million private placement of equity. The most recent rating by B. Riley FBR Inc., on March 28, 2018, is a Neutral.
Range Resources Corporation (RRC) stock plunged -4.79% to $7.35 in the pre-market trading. The most recent rating by Stephens, on November 16, 2020, is an Overweight.
Zedge Inc. (AMEX: ZDGE) shares are trading up 23.7% at $6.68 at the time of writing after reporting first fiscal quarter revenue growth of 85% and record overall quarterly financial results. Company’s 52-week ranged between $0.66 to $4.70. Analysts have a consensus price target of $3.
Hennessy Capital Acquisition Corp. IV (HCAC), a Shell Companies company, dropped about -5.82% at $20.72 in pre-market trading Friday.
Editas Medicine Inc. (EDIT) grew over 0.84% at $67.4 in pre-market trading today. The company recently publicized submission of IND application for EDIT-301 with the FDA.
Greenwich LifeSciences Inc. (GLSI) is down more than -9.3% at $65.5 in pre-market hours Friday December 11, 2020 following the today’s announcement of poster presentation on its GP2 phase III clinical trial design for recurring breast cancer. The stock had jumped over 26.48% to $72.22 in the last trading session.
Silver Spike Acquisition Corp. (SSPK) is down more than -2.78% at $14.0 in pre-market hours Friday December 11, 2020. The stock had jumped over 37.27% to $14.40 in the last trading session.
Biocept Inc. (BIOC) stock plunged -3.07% to $5.68 in the pre-market trading after declaring results from a prospective study showing Target Selector™ was highly accurate in monitoring HER2 alterations in patients with metastatic breast cancer. The most recent rating by Chardan Capital Markets, on November 14, 2017, is a Buy.
W&T Offshore Inc. (NYSE: WTI) shares are trading down -6.02% at $2.5 at the time of writing following the firm provided an operational update regarding fourth quarter 2020 production. Company’s 52-week ranged between $1.07 to $6.10.
Before the trading started on December 11, 2020, Platinum Group Metals Ltd. (PLG) is up 1.93% to reach $5.27. It has been trading in a 52-week range of $0.86 to $5.20.
Aytu BioScience Inc. (AYTU), a Biotechnology company, dropped about -24.72% at $6.12 in pre-market trading Friday after the company and Neos Therapeutics declared definitive merger agreement pursuant to which Neos will merge with a wholly owned subsidiary of Aytu in an all-stock transaction.
Torchlight Energy Resources Inc. (TRCH) stock soared 13.78% to $0.7226 in the pre-market trading. The most recent rating by ROTH Capital, on March 13, 2020, is a Neutral.
Before the trading started on December 11, 2020, Energy Fuels Inc. (UUUU) is up 1.64% to reach $3.1 following the announcement from the company that that its President and CEO Mark S. Chalmers will be presenting live at the 13th Annual LD Micro Main Event investor conference on Monday, December 14, 2020 at 11:40 AM (EST). It has been trading in a 52-week range of $0.78 to $2.99.
Ashford Hospitality Trust Inc. (NYSE: AHT) shares are trading up 8.04% at $4.3 at the time of writing. Company’s 52-week ranged between $1.27 to $29.44.
ClearOne Inc. (CLRO) stock plunged -7.2% to $2.45 in the pre-market trading after declaring that it has appointed Chromasound PLC, based in Budapest, Hungary, as its newest distribution partner. The most recent rating by Singular Research, on August 16, 2018, is a Buy – long-term.
ReWalk Robotics Ltd. (NASDAQ: RWLK) shares are trading up 3.7% at $1.4 at the time of writing after revealing a contract with a German private health insurance company to allow all eligible beneficiaries with spinal cord injury (SCIs) to apply for the procurement of a ReWalk 6.0 exoskeleton system. Company’s 52-week ranged between $0.41 to $2.71. Analysts have a consensus price target of $1.50.
Progenity Inc. (PROG) grew over 9.32% at $4.34 in pre-market trading today. The firm recently reported closing of the convertible senior notes offering and partial exercise of the Initial purchaser’s option to purchase additional notes.
Boxlight Corporation (BOXL) is down more than -7.69% at $1.8 in pre-market hours Friday December 11, 2020. The stock had jumped over 17.47% to $1.95 in the last trading session.
Lemonade Inc. (LMND), a Insurance – Property & Casualty company, rose about 0.7% at $100.4 in pre-market trading Friday. The company recently declared that residents of France can now get renters insurance instantly, anytime, and from any device – as well as file claims and get paid in seconds through the Lemonade app.
ObsEva SA (OBSV) lost over -2.54% at $2.3 in pre-market trading Friday December 11, 2020 after announcing topline 52-week PRIMROSE 1 and 76-week PRIMROSE 2 results of Yselty, in development for the treatment of women with heavy menstrual bleeding due to uterine fibroids.
Amplify Energy Corp. (AMPY) is down more than -27.33% at $1.09 in pre-market hours Friday December 11, 2020 following the commencement of an underwritten public offering of 8,548,485 shares of its common stock by certain of its stockholders which are affiliates of Fir Tree Capital Management L.P. The stock had jumped over 11.94% to $1.50 in the last trading session.
Before the trading started on December 11, 2020, Hoth Therapeutics Inc. (HOTH) is up 0.54% to reach $1.85 after the firm revealed that it has received approval to commence phase 1b clinical trial of BioLexa for the treatment of Atopic Dermatitis in humans. It has been trading in a 52-week range of $1.60 to $7.25.
RMG Acquisition Corp. (RMG) grew over 6.6% at $22.29 in pre-market trading today after declaring stockholder meeting Date of December 28, 2020.
Marathon Patent Group Inc. (MARA) is down more than -10.34% at $4.68 in pre-market hours Friday December 11, 2020. The company recently stated that it has entered into a contract with Bitmain to purchase 10,000 Antminer S-19j Pro ASIC Miners. The stock had jumped over 9.21% to $5.22 in the last trading session.
Before the trading started on December 11, 2020, Inseego Corp. (INSG) is up 7.26% to reach $13.15. The firm today reported that the it is expanding its global footprint in Japan with the launch of its industry-leading 5G MiFi® M2000 mobile hotspot. It has been trading in a 52-week range of $3.91 to $15.25.
Entera Bio Ltd. (ENTX) tumbled over -7.56% at $1.1 in pre-market trading today after revealing FDA approval of IND application for EB613 – an oral human Parathyroid Hormone (1-34) for the treatment of Osteoporosis.
OncoCyte Corporation (OCX) stock moved up 3.23 percent to $2.24 in the pre-market trading. The firm recently reported that it will host a key opinion leader (KOL) call on the Company’s proprietary DetermaRx™ and DetermaIO™ molecular tests for cancer treatment selection on Tuesday, December 15, 2020 at 11:00am Eastern Time.
ZK International Group Co. Ltd. (ZKIN) lost over -4.98% at $2.1 in pre-market trading Friday December 11, 2020 after declaring that it signed a letter of intent with Tuopeng Industrial, a prominent construction and real estate company.
Before the trading started on December 11, 2020, Arbutus Biopharma Corporation (ABUS) is up 15.8% to reach $4.25. It has been trading in a 52-week range of $0.88 to $9.02 following the declaration of additional clinical data from an ongoing Phase 1a/1b clinical trial (AB-729-001) with AB-729, its proprietary GalNAc delivered RNAi compound.
Tag: Zedge stock
-
Market Movers: What changed for these 37 stocks while you were sleeping
-
Early Morning Vibes: 3 Upgraded & 4 Pre Market Hot Stocks Inside
On December 10, the American stock indexes finished trading in different directions. The S&P 500 Index dropped 0.13% to 3668 points, the Dow Jones lost 0.23% and the NASDAQ rose 0.54%. Investors could not determine the direction of movement and took a wait and see attitude. Note that small-cap stocks showed more pronounced positive dynamics: the Russel 2000 index rose 1.08%. The industrial sector was an outsider, shedding 0.93%.
Corporate updates
Starbucks (SBUX: 5%) management presented a positive outlook for the company over the next few years.
Snap (SNAP: + 8.1%) and Twitter (TWTR: + 8.4%) have announced a service integration partnership. Tweets can be shared on the Snapchat platform.
Adobe’s quarterly results (ADBE: -1.4%) were better than expected, but its stock corrected.
Today, global stock exchanges are showing mostly negative dynamics. The focus of attention is the decision of the FDA expert panel, which recommended approval of the coronavirus vaccine developed by Pfizer and BioNTech. However, no official permission was issued for the use of this drug, although market participants were counting on this. The market now assumes that a positive decision will be made this weekend, and then within 24 hours the first 6.4 million doses will be shipped to different states. Waiting for a vaccine approval within three months was the main driver of market growth.
Lack of further progress in negotiations on the US economic aid package, persisting tensions with China and COVID-19 incidence statistics are factors that reduce risk appetite in the short term. The alarming signal yesterday was the publication of data on applications for unemployment benefits. Their number unexpectedly increased to 853 thousand in a week, while the forecast was 725 thousand. Macro statistics were ignored by the market, however, in our opinion, it serves as a harbinger of a deterioration in the state of the economy in early 2021 due to quarantine restrictions reintroduced by some states.
Economic Update
The University of Michigan Preliminary Expectations and Consumer Sentiment Index for December will be released today. The consensus assumes an increase in the first indicator from 70.5 to 71.0, while the second decreases from 76.9 to 76.5 points. The Expectations Index should be boosted by consumer hopes for mass vaccinations. Before the pandemic, the sentiment index was at the level of 99-100, the pressure on it continues to be the absence of a new package of economic assistance measures and stabilization of the epidemiological situation.
Top Upgrades & Downgrades
Morgan Stanley turned bullish on Diamondback Energy Inc. (FANG), upgrading the stock to “Overweight” and assigning a $65.0 price target.
CommScope Holding Company Inc. (COMM) has won the favor of JP Morgan’s equity research team. The firm upgraded the shares from Neutral to Overweight and moved their price target to $18.0.
Cognizant Technology Solutions Corporation (CTSH) received an upgrade from analysts at JP Morgan, who also set their one-year price target on the stock to $93.0. They changed their rating on CTSH to Overweight from Neutral in a recently issued research note.
Earlier Friday JP Morgan reduced its rating on Juniper Networks Inc. (JNPR) stock to Neutral from Overweight and assigned the price target to $25.0.
JP Morgan analysts reduced their investment ratings, saying in research reports covered by the media that its rating for Corning Incorporated (GLW) has been changed to Neutral from Overweight and the new price target is set at $39.0.
Today Top Movers
vTv Therapeutics Inc (VTVT) share price soared 184.47% at $6.23 in today’s pre-market session after the report that in compliance with the terms of the letter arrangement between the Firm and the Investor dated December 23, 2019, the company exercised the right to allow MacAndrews & Forbes Group LLC buy 625,000 shares of the Company’s Class A common stock at a per share price of $1.60.
In trading session of premarket today, BioNTech SE (BNTX) share price went up 0.07% at $29.63 after the company and Pfizer reported the receipt FDA advisory committee vote in supporting potential first emergency use authorization for vaccine to combat COVID-19 in the U.S.
Sonoma Pharmaceuticals Inc (SNOA) showing bullish trend in early morning on Friday, increasing 33.44% of its share price at $8.18 following an announcement of agreement with Crown Laboratories, Inc., to Launch Microcyn technology-based anti-Itch over-the-counter products.
Zedge Inc (ZDGE) is going up 21.48% in premarket session on Friday after reporting first fiscal quarter revenue growth of 85% and record overall quarterly financial results.
Latest Insider Activity
Advanced Micro Devices Inc. (AMD) President & CEO Su Lisa T announced the sale of shares taking place on Dec 08 at $92.89 for some 150,000 shares. The total came to more than $13.93 million.
Twitter Inc. (TWTR) Chief Financial Officer SEGAL NED D. sold on Dec 08 a total 634,970 shares at $47.93 on average. The insider’s sale generated proceeds of almost $0.34 million.
Regulus Therapeutics Inc. (RGLS) 10% Owner Sonsini Peter W. declared the purchase of shares taking place on Dec 04 at $0.62 for some 4,398,602 shares. The transaction amount was around $2.74 million.
Boxlight Corporation (BOXL) CHIEF EXECUTIVE OFFICER Pope Michael Ross bought on Dec 09 a total 287,942 shares at $1.65 on average. The purchase cost the insider an estimated $66,000.
Earnings To Watch
Top US earnings releases scheduled for today include Construction Partners Inc. (NASDAQ:ROAD). It will announce its Sep 2020 financial results. The company is expected to report earnings of $0.3 per share from revenues of $241.5M in the three-month period.
Analysts expect Johnson Outdoors Inc. (NASDAQ:JOUT) to report a net income (adjusted) of $0.8 per share, when the bank releases its quarterly results shortly. Revenue for the fiscal quarter ended Sep 2020 is predicted to come in at $125.44M.
-
Lets, not forget the reason why Zedge, Inc. (NYSE: ZDGE) surged in the after-hours last night
Zedge, Inc. (NYSE: ZDGE) stock jumped 28.33% to reach $6.93 in the post-market session. After a leading global mobile phone personalization and entertainment app, released its first-quarter 2021 results today.
We achieved year-over-year growth in monthly active users (MAU), and subscription revenue grew 214%. These two factors drove our average revenue per monthly active user (ARPMAU) up 73%, said Jonathan Reich, chief executive officer.
ZDGE Earnings Underlines
The company’s record revenues of $3.8 million increased by 85.0% from $2.0 million last year. Compared to last year, the number of paid subscribers and subscription revenues increased by 214% and 205%, respectively. Compared with last year’s operating loss of ($0.7) million and (36.6%)%, this year’s operating profit of $1.1 million and operating margin of 29.1% are records.
Cash flow from operations increased 322% to a new record of $1.5 million versus $0.4 million a year ago, for the 5th consecutive quarter.
The EBITDA1 for the quarter was $1.4 million versus ($0.3) million a year ago; average monthly active users increased by 9.1% compared to last year. In comparison to last year, Zedge Premium Gross Transaction Value (GTV) increased by 8.3%.